Raymond James Financial Inc Immunic, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 2,025 shares of IMUX stock, worth $1,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,025Holding current value
$1,923% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
63Shares Held
50MCall Options Held
13.2KPut Options Held
60.6K-
Abrdn PLC8.24MShares$7.83 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$7.27 Million0.21% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.93 Million0.4% of portfolio
-
Avidity Partners Management LP Dallas, TX5.62MShares$5.34 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$3.92 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $29M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...